The phase 3 IMforte trial(NCT05091567) demonstrated benefit for expanding on maintenance immunotherapy in extensive-stage ...
This clinical trial will determine whether focused ultrasound can safely and effectively treat metastatic brain tumors when ...
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
Misusing the words cancer and tumour can be confusing and misleading. This may be because the word "cancer" carries a stigma ...
Morning Overview on MSN
Why cancer returns years later, and how we can stop it
Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
-- Proceeds to drive global Phase 3 trial for ASP-1929, targeting BLA submission to the U.S. FDA in 2028 -- Financing led by international life science fund TaiAx, with participation from the largest ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
They plan to run similar trials on seven more patients over the next three years, backed by $4 million from the National ...
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Morning Overview on MSN
1 protein block slowed cancer in mice, and it’s a promising target
Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases ...
Optune Lua adoption lag hit shares, but 2026 catalysts and $230M net cash could drive a rebound. Know more about NVCR stock ...
After eight years of training, Dr. Maureen McKiernan made her debut as the lead surgeon on an infant heart transplant — an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback